American Oncology Network Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for American Oncology Network Inc in the fourth quarter 2024?
Due to the lack of equity, it was not possible to calculate American Oncology Network Inc 's return on equity (ROE) in its fourth quarter 2024

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-27	-35	-35	-42	-19
Return On Equity (TTM)	-	-	-	-	-
AONC's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-45	-103	-39	-167	-161
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	-	-	-	-

Back to AONC Management Effectiveness >> AONC's 5 Years Annual ROE >> Compare AONC ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

AONC Annual Return On Equity	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	-45	-161	-14	-21	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	-27	-63	11	8	0
Y / Y Net Income Change	-	-	25.47 %	-	-
Return On Equity	-	-	-	-	-

Back to AONC Management Effectiveness >> AONC's 5 Years Annual ROE >> Compare AONC ROE to its Competitors

Annual Roe Comment

In 2024 ROE improved to 25.47 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
AONC's' Return on Equity at Yahoo Finance
AONC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for AONC's Competitors
Subscribers only: Roe for American Oncology Network Inc 's Suppliers
Subscribers only: Return On Equity for AONC's Customers

Companies with similar Return On Equity at Dec 31 2024, within Healthcare Sector	ROE
Eli Lilly And Company	76.84 %
Tenet Healthcare Corp	76.52 %
Addex Therapeutics Ltd	75.10 %
Novo Nordisk A	73.56 %
Abbvie Inc	70.54 %
Nrc Health	69.30 %
Amgen Inc	67.18 %
Dariohealth Corp	61.81 %
Agios Pharmaceuticals Inc	58.94 %
Idexx Laboratories Inc	55.82 %
Exelixis Inc	54.88 %
Promis Neurosciences inc	51.55 %
Medpace Holdings Inc	51.48 %
Zoetis Inc	49.70 %
Pharmacyte Biotech Inc	49.09 %
Edwards Lifesciences Corporation	48.53 %
Protagonist Therapeutics inc	47.67 %
Sbc Medical Group Holdings Incorporated	47.47 %
Carlisle Companies Incorporated	47.32 %
Puma Biotechnology Inc	46.10 %
Galmed Pharmaceuticals Ltd	45.94 %
Waters Corporation	41.68 %
Insulet Corporation	40.62 %
Acadia Pharmaceuticals Inc	39.54 %
Merck and Co Inc	39.16 %
Semler Scientific inc	34.63 %
Medinotec Inc	34.27 %
Entrada Therapeutics Inc	34.08 %
Siga Technologies Inc	33.00 %
Abbott Laboratories	32.19 %

Date modified: 2026-09-08T15:11:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.